Sierra Oncology, Inc.

Informe Stock NasdaqGM:SRRA

Capitalización de mercado: US$1.3b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Salud financiera de hoja de balance de Sierra Oncology

Salud financiera controles de criterios 5/6

Información clave

1.9%

Ratio deuda-patrimonio

US$4.86m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$274.02m
PatrimonioUS$261.62m
Total pasivoUS$18.38m
Activos totalesUS$280.00m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: SRRA's short term assets ($278.2M) exceed its short term liabilities ($13.1M).

Pasivo a largo plazo: SRRA's short term assets ($278.2M) exceed its long term liabilities ($5.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: SRRA has more cash than its total debt.

Reducción de la deuda: Insufficient data to determine if SRRA's debt to equity ratio has reduced over the past 5 years.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: SRRA has sufficient cash runway for more than 3 years based on its current free cash flow.

Pronóstico de cash runway: SRRA has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 13.3% each year.


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target